一位金色长发的女士身穿黑色无袖上衣,戴着项链,站在明亮、模糊的公司法律办公室环境中微笑。

Monica R. Chmielewski

合作伙伴

Monica R. Chmielewski

合作伙伴

Monica R. Chmielewski is a health care and life sciences lawyer solely focused on the representation of health care providers, pharmaceutical, biotech and medical device companies, and pharmacies in life sciences law, health care, health care transactions, clinical research, supply chain, and food and drug law. She has experience assisting clients with regards to all aspects of medical research, development and commercialization, including regarding the regulation and conduct of clinical trials and decentralized clinical trials, FDA submissions and pharmaceutical and medical device manufacturing, licensing and commercialization assistance. She is a partner and vice chair of the firm’s Health Care Practice Group.

代表经验

Regulatory Compliance, Clinical Research, and Supply Chain

Monica provides daily counsel to numerous health systems, hospitals, academic medical centers, pharmacies and biotech, pharmaceutical and medical device companies. As such, she regularly assists clients with the following issues:

  • Regulatory compliance governing all aspects of clinical research
  • Investigations of research misconduct
  • Institutional Review Board (IRB) issues
  • The conduct of U.S. and international clinical trials
  • Research grants and funding
  • Government investigations and audits
  • Pharmaceutical product promotion (including counsel on off-label promotion)
  • 510K applications
  • The regulation of software as a medical device
  • Mobile medical applications
  • Continuing Medical Education (CME)
  • Preparation of research contracts
  • Grant contracts and administration
  • Pharmacy Benefit Managers (PBM) matters
  • Good clinical practice (GCP) issues
  • Customs import and export issues
  • Hospital and physician issues
  • Supply chain matters (including formation of and contracting with group purchasing organizations)
  • Corporate practice of medicine and dentistry prohibitions
  • Joint venture and other collaborative efforts
  • Preparation and review of hospital
  • Physician and other provider contracts
  • Accountable care organization (ACO) formation and operation
  • HIPAA
  • Physician recruitment
  • Corporate compliance issues
  • Medical staff and peer review
  • Accreditation matters
  • Supply chain and procurement issues

She also has participated as transactional counsel in numerous health care, life science, and corporate transactions, including the merger, purchase and sale, or transfer of sponsorship of hospitals, pharmacies, contract research organizations (CROs), physician-owned surgery centers, health systems, home health agencies, hospices and physician practices; and the formation of ancillary services joint ventures; and counsels investors (venture capital and private equity) in investments, acquisitions, and sales.

Monica has in-depth knowledge of federal and state regulation of the drug and device supply chain, pharmacies, and laboratories. She advises entities (industry), health care providers, investors, and lenders on transactional matters and regulatory compliance, including mergers and acquisitions, recapitalizations, buyouts, restructurings, joint ventures, and broad range of commercial transactions.

Monica provides daily counsel on supply chain and materials management issues, and counsels on group purchasing organization (GPO) negotiations and formation. She also counsels health plans in their procurement of and contracting with PBMs for mail, retail, and specialty drug services in connection with commercial and government health care programs. In addition, she provides counsel regarding PBM audits, as well as on regulatory issues for various retail and specialty pharmacies, including state Boards of Pharmacy inspection and adverse findings, compounding pharmacy matters, and licensure among others.

合规性

Monica counsels health care entities, pharmaceutical and medical device companies, pharmacies and laboratories regarding the operation and functions of their corporate compliance and integrity programs, including assisting with the composition and development of programs; reviewing and assessing existing program effectiveness; providing compliance education and training of personnel, executive management and board members; coordinating internal investigations of compliance related concerns; and recommending any needed corrective action. She has counseled, in both in-house and outside counsel roles, individual hospitals, health systems, hospices, skilled nursing facilities, and pharmaceutical companies on matters of corporate compliance.

远程医疗

“Foley is the premier firm for telehealth counsel.”
“A market leader in telemedicine issues.” “This is the Dream Team.”
– Chambers USA: America’s Leading Business Lawyers (2020, 2021)

Monica advises a number of clients, including hospitals, health systems and physician groups on regulatory and compliance issues presented by telemedicine and telehealth. Her counsel includes, but is not limited to, structuring, and negotiating professional services agreements for telemedicine services and composing telemedicine policies and procures.

Fraud and Abuse, False Claim Act, and Health Care Fraud Investigations

Monica’s experience includes particular compliance issues arising under the False Claims Act (FCA), Stark Law, Anti-Kickback Statute, EMTALA, Civil Monetary Penalties Law, licensure/certification, and HIPAA. Monica works with providers on properly responding to governmental and accreditation audits and more formal investigations as well as directly with provider compliance officers and general counsel to advise them on the latest legal and Office of Inspector General requirements and standards.

奖项与表彰

  • Chambers USA: America’s Leading Business Lawyers, Healthcare: Pharmaceutical/Medical Products Regulatory (2020-2025)
  • The Legal 500, Life Sciences (2014)
  • Named a Thomson Reuters Stand-out Lawyer (2023-2024)

演讲和出版物

  • 合著,"GLP-1 受体激动剂:临床试验注意事项》,《今日医疗保健法》(2025 年 7 月 22 日)
  • 与他人合著,"德克萨斯州法院撤销 FDA 的实验室开发测试 (LDT) 最终规则",《今日医疗保健法》(2025 年 4 月 2 日)
  • 合著,"FDA & OHRP Draft Guidance:将组织活检纳入临床试验》,《今日医疗法》(2025 年 2 月 3 日)
  • 合著,"FDA Clinical Investigations:电子系统新指南》,《今日医疗法》(2024 年 11 月 20 日)
  • 合著,"Cancer Drugs:抗体药物共轭物 (ADC) / 抗体疗法的临床试验问题》,《今日医疗保健法》(2024 年 11 月 5 日)
  • Speaker, “Medical Research Misconduct Proceedings: New HHS-ORI Final Rule; Key Procedural Reforms and Requirements,“ Strafford Webinar (December 4, 2024)
  • 合著,"Decentralized Clinical Trials:研究不当行为风险与如何避免》,《今日医疗法》(2024 年 9 月 30 日)
  • Speaker, “Examine the Recent FDA Guidance Surrounding Digital Health Technologies,“ 5th Clinical Trial Agreements (August 22, 2024)
  • Co-author, “Clinical Trials: FDA Publishes Draft Guidance on Diversity Action Plans,” Health Care Law Today (July 25, 2024)
2025年9月18日 活动

GLP-1药物聚焦:趋势、需求与未来展望

福莱国际医疗健康与生命科学及创新技术业务部诚邀您参加网络研讨会,探讨贵机构如何在GLP-1类药物发展的十字路口把握机遇,为不断演变的行业格局做好准备。
October 6, 2025 Events

Women, Influence & Power in Law Conference 2025

ALM will be hosting its annual Women, Influence & Power in Law conference on October 6-8 in Washington D.C. at the Gaylord National Resort & Convention Center.
A scientist wearing protective glasses examines samples under a microscope while holding two test tubes in a laboratory, providing crucial research that can aid intellectual property law and litigation support for lawyers in Chicago.
July 22, 2025 Health Care Law Today

GLP-1受体激动剂:临床试验考量

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
壁挂式医疗设备,包括血压计、耳镜、眼底镜、体温计和一次性盖子容器,通常出现在提供现场医疗服务的芝加哥律师事务所的临床环境中。
2025 年 7 月 16 日 今日保健法》播客

第 36 集:让我们谈谈合规性:医疗保健供应链合规的风险和陷阱

在本期节目中,富理达医疗保健业务组副主席 Monica Chmielewski 和首席合规官、PYA 纳什维尔办事处管理负责人 Shannon Sumner 将探讨供应链合规对医疗保健行业的影响,并分享不合规所带来的风险和惩罚。
July 23, 2025 Events

Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact

Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.
2025 年 6 月 5 日 新闻发布

富理达在 2025 年《钱伯斯美国》杂志中名列前茅

Foley & Lardner LLP 很荣幸再次被《钱伯斯与合伙人》(Chambers & Partners)评为 2025 年版《钱伯斯美国:美国商业领先律师》(Chambers USA: America's Leading Lawyers for Business)中的美国领先律师事务所之一。